News
21 February 2020

UICC Selects ASCP to host 2021 World Cancer Leaders’ Summit in Boston

The American Society for Clinical Pathology (ASCP) has been selected to host the 2021 World Cancer Leaders’ Summit in Boston, Massachusetts in October 2021.

Header Paragraph

The prestigious, invitation-only event—organised by the Union for International Cancer Control (UICC)— brings together key decision-makers including prime ministers, ministers of health, city and industry leaders, senior executives and other influential players from around the world to facilitate debates about emerging issues related to cancer control.

 “The choice of Boston is rooted in the city’s crucial role in global cancer innovation and domestic cancer control leadership in the United States,” said Dr Cary Adams, Chief Executive Officer of the UICC. “With many of the country’s thought health leaders in Boston, the 2021 Summit will launch renewed domestic and global efforts to combat the disease.”

The 2021 Summit focus will be developed in the coming months and will centre around both domestic challenges for cancer in the United States as well as global challenges in cancer control. More than 350 global influencers and leaders are expected to attend the event.

For the past five years, the Summit has grown to become a major, annual high-level policy meeting dedicated exclusively to furthering global cancer control. It provides an important forum to secure a coordinated, multi-level global response to address the spiralling cancer epidemic. The last World Cancer Leaders’ Summit in Kazakhstan ended with a strong call to action urging governments to fulfil their commitments to Universal Health Coverage.

The Summit is held in partnership with the World Health Organization (WHO), the International Agency for Research on Cancer (IARC) and the International Atomic Energy Agency (IAEA), and is hosted by a UICC-member organisation from the region.

ASCP is the world’s largest organisation for pathologists and laboratory professionals supporting activity in more than 100 countries. The Society’s global health initiatives have focused on HIV and cancer, with efforts on the latter currently taking place in more than 20 countries and in collaboration with more than 80 organisations, from academia to industry, governments and NGOs.

Last update

Friday 21 February 2020

Share this page